Latest stories on MXCT
MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer
Business Insider55 · neutralgeneral
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire50 · neutralgeneral
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
StockTitan50 · neutralgeneral
MaxCyte stock rating held at Neutral by BTIG after Q2 results
Investing.com Analyst Ratings50 · neutralanalyst
MaxCyte (MXCT) Q2 2026 Earnings Call Transcript
Yahoo Top56 · neutralearnings
MaxCyte (MXCT) Q2 2026 Earnings Call Transcript
The Motley Fool56 · neutralearnings
MaxCyte launches CHANGE-seq-BE™ and ONE-seq-BE™ to strengthen off-target assessment for genome editing therapies
Business Insider63 · neutralproduct/pr
Strategic Genentech Partnership and Strong Cost Controls Mark Key Shifts in MaxCyte’s Second Quarter 2026
August 13, 2026
MarketChameleon63 · neutralproduct/pr
MaxCyte, Inc. Q2 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
MaxCyte reiterates $30M-$32M 2026 revenue outlook as Genentech partnership expands enterprise model
Seeking Alpha63 · neutralproduct/pr
MaxCyte, Inc. (MXCT) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
MaxCyte GAAP EPS of -$0.08 beats by $0.01, revenue of $7.27M beats by $0.8M
Seeking Alpha56 · neutralearnings
MAXCYTE, INC. (MXCT) files 8-K
SEC 8-K50 · neutralgeneral
MaxCyte Reports Second Quarter 2026 Financial Results
GlobeNewswire56 · neutralearnings
MaxCyte® Announces Multi-Platform Technology License Partnership with Genentech® to Advance Cell Therapy Development
Business Insider66 · bullishproduct/pr
MaxCyte Shareholders Reelect Directors and Ratify Auditor
TipRanks50 · neutralgeneral
MaxCyte Regains Nasdaq Compliance After Bid Price Recovery
TipRanks58 · neutralgeneral
MAXCYTE, INC. (MXCT) files 8-K
SEC 8-K34 · bearishgeneral
Here’s Why MaxCyte (MXCT) is Becoming a High-Conviction Bet for Investors
Yahoo Finance67 · bullishgeneral
Cisco, Alibaba And 3 Stocks To Watch Heading Into Wednesday
Yahoo Finance57 · neutralearnings
MaxCyte, Inc. Q1 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings